Kumar A, Cole A, Segal J, Smith P, Limdi J
Therap Adv Gastroenterol. 2022; 15:17562848221078456.
PMID: 35198041
PMC: 8859667.
DOI: 10.1177/17562848221078456.
Barnich N, Darfeuille-Michaud A
World J Gastroenterol. 2007; 13(42):5571-6.
PMID: 17948930
PMC: 4172735.
DOI: 10.3748/wjg.v13.i42.5571.
Lal S, Steinhart A
Can J Gastroenterol. 2006; 20(10):651-5.
PMID: 17066156
PMC: 2660793.
DOI: 10.1155/2006/250490.
DHaens G
Curr Gastroenterol Rep. 2000; 1(6):476-81.
PMID: 10980989
DOI: 10.1007/s11894-999-0006-6.
Bernell O, Lapidus A, Hellers G
Ann Surg. 2000; 231(1):38-45.
PMID: 10636100
PMC: 1420963.
DOI: 10.1097/00000658-200001000-00006.
Metronidazole. A therapeutic review and update.
Freeman C, Klutman N, Lamp K
Drugs. 1997; 54(5):679-708.
PMID: 9360057
DOI: 10.2165/00003495-199754050-00003.
Management of rectourethral fistulas in Crohn's disease.
Santoro G, Bucci L, Frizelle F
Int J Colorectal Dis. 1995; 10(4):183-8.
PMID: 8568400
DOI: 10.1007/BF00346215.
Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.
Winslet M, Allan A, Poxon V, Youngs D, Keighley M
Gut. 1994; 35(2):236-42.
PMID: 8307475
PMC: 1374500.
DOI: 10.1136/gut.35.2.236.
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
Krook A, Lindstrom B, Kjellander J, Jarnerot G, Bodin L
J Clin Pathol. 1981; 34(6):645-50.
PMID: 7251906
PMC: 493641.
DOI: 10.1136/jcp.34.6.645.
Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?.
SHORTER R
Gastroenterol Jpn. 1982; 17(5):476-88.
PMID: 6757043
DOI: 10.1007/BF02774726.
Inflammatory bowel disease in childhood.
Booth I, HARRIES J
Gut. 1984; 25(2):188-202.
PMID: 6363218
PMC: 1432245.
DOI: 10.1136/gut.25.2.188.
Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice.
Chacko M, Bhide S
J Cancer Res Clin Oncol. 1986; 112(2):135-40.
PMID: 3771623
DOI: 10.1007/BF00404396.
Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management.
Nelson Jr E, Bright D, Villar L
Dig Dis Sci. 1990; 35(12):1561-5.
PMID: 2253542
DOI: 10.1007/BF01540577.
Double blind, placebo controlled trial of metronidazole in Crohn's disease.
Sutherland L, Singleton J, Sessions J, Hanauer S, Krawitt E, Rankin G
Gut. 1991; 32(9):1071-5.
PMID: 1916494
PMC: 1379053.
DOI: 10.1136/gut.32.9.1071.
Letter: Brain abscess.
Ingham H, Selkon J, So S, Weiser R
Br Med J. 1975; 4(5987):39-40.
PMID: 1174915
PMC: 1674743.
DOI: 10.1136/bmj.4.5987.39-a.
Metronidazole neuropathy.
Br Med J. 1977; 2(6090):832.
PMID: 912357
PMC: 1631961.
Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group.
Peach S, Lock M, Katz D, TODD I, TABAQCHALI S
Gut. 1978; 19(11):1034-42.
PMID: 730070
PMC: 1412245.
DOI: 10.1136/gut.19.11.1034.
14C-Glycocholate test in Crohn's disease--its value in assessment and treatment.
Scarpello J, Sladen G
Gut. 1977; 18(9):736-41.
PMID: 604195
PMC: 1411645.
DOI: 10.1136/gut.18.9.736.
Treatment of infections due to nonsporing anaerobes.
Sprott M, Ingham H
Drugs. 1979; 18(2):137-49.
PMID: 487957
DOI: 10.2165/00003495-197918020-00006.
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.
Brogden R, Heel R, Speight T, Avery G
Drugs. 1978; 16(5):387-417.
PMID: 363399
DOI: 10.2165/00003495-197816050-00002.